Atlas Trials

Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus

Clinical trial NCT04046133 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04046133
Sponsor
Cardiff University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Anal Cancer Stage III AAnal Cancer Stage III B
Start date
2020-10-19
Primary completion
2026-11-30
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.